- wöchentlichErscheinungsrhythmus
- 29 mintypische Länge
- vor 3 Tagenletzte Folge
Folgenzu den neuesten
Why are Executives Paid So Much?
Why and how did CEO paychecks become so massive and divisive? Who decides what leaders are worth? And what’s the ripple effect on companies, workers, and the economy? Host Curt Nickisch unpacks these issues and more with Charles Tharp, Prof
Regulating Platforms & Speech in an Age of Fake News
How do we reconcile the protection of free speech with the need to prevent harmful misinformation from spreading online? Is it even possible to strike a balance? Host Curt Nickisch speaks to Marshall Van Alstyne, the Allen and Kelli Questro
How Can We Understand Online Misinformation?
From political lies to viral conspiracy theories, misinformation has reshaped our digital landscape—creating confusion, influencing public perception, and altering national debates. Just how widespread has misinformation become? What are th
Shareholder Primacy vs. Stakeholderism: 5 Years Later (Pt 2)
Last week's episode features the first part of a panel centered around the Business Round Table's pledge five years ago to redefine the purpose of a corporation, by create value for all stakeholders, not just shareholders. Today, we continu
Shareholder Primacy vs. Stakeholderism: 5 Years Later (Pt 1)
Five years ago, the Business Roundtable made a bold move and redefined the purpose of a corporation. 181 CEOs signed a pledge to create value for all stakeholders in a corporation, instead of just shareholders. What, if anything, has change
Why Cell and Gene Therapies Cost So Much – And What Can Be Done
Last week's episode introduced the promises and challenges brought forth by Cell and Gene Therapies. Today's show dives deeper into this topic with BU Questrom Professor Rena Conti, an expert on the financing and regulation of the biopharma
Life Science Innovation: Who Should Pay?
Sometimes called “living drugs,” Cell and Gene Therapies have the potential to cure an individual of a rare disease by modifying that person’s genes. But due to the labor-intensive, individualized treatment, these drugs are expensive, to th
The Future of ESG: Where Do We Go From Here?
The future of ESG, or Environmental Social Governance, depends on how we approach our current moment, according to today's show guests. Host Curt Nickisch talks with Bob Eccles, Visiting Professor of Management Practice at Saïd Business Sch
What Are Today’s Business Leaders Saying About ESG?
What do the conversations around ESG, or Environmental Social Governance, look like today? How are businesses addressing E, S, and G factors in what they do? This episode explores how ESG looks on the ground. Host Curt Nickisch talks with M
Revisiting ESG: How Did We Get Here?
ESG, or Environmental Social Governance, isn't the first time business has attempted addressing public concerns regarding the social impact of business. In this episode, Host Curt Nickisch invites John Streur, former Chair CEO of Calvert Re
Promises and Perils of the ESG Movement
ESG, or Environmental Social Governance, promises to help the bottom line and the planet at the same time. Is it too good to be true? In this episode, Host Curt Nickisch moderates a live debate between Witold Henisz of the Wharton School an
Is Business Broken?
Host Curt Nickisch and Susan Fournier, Allen Questrom Professor and Dean of Questrom School of Business at Boston University, preview the arc of this podcast and unpack the thorny questions percolating about business and capitalism today. L
Trailer: "Is Business Broken?"
A preview of "Is Business Broken?" - Conversations about the role of business in society, brought to you by the Ravi K. Mehrotra Institute for Business, Markets & Society at BU Questrom School of Business. Learn more about your ad choices.